Skip to content

Pedometers for Gestational Diabetes

Type 2 Diabetes Risk in Women With Gestational Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00862602
Acronym
PEG
Enrollment
60
Registered
2009-03-17
Start date
2009-07-31
Completion date
2010-11-30
Last updated
2017-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes

Keywords

GDM, gestational diabetes, pregnancy, diabetes, walking, exercise, pedometer, online

Brief summary

Ten to 50% of women with gestational diabetes (GDM), or glucose intolerance first recognized during pregnancy, develop diabetes within 5 years after delivery. Although intensive interventions can reduce diabetes incidence in women with impaired glucose tolerance, it is unknown if such strategies would be effective in women with GDM. Women with recent GDM, even though no longer pregnant, face significant barriers to lifestyle modification, including caregiving responsibilities and low perception of risk. Web-based programs can reinforce physical activity through visual feedback of pedometer output, tailored messaging, education, and on-line communities. Such a program is currently available for adults with chronic disease and is led by Dr. Richardson, a co-PI on this application. Using data from focus group and survey work conducted by Dr. Kim, the other co-PI, this program can be modified to women with recent GDM. For Specific Aim 1, we propose to adapt a chronic disease web-based pedometer program to women with recent GDM. For Specific Aim 2, we propose to conduct a pilot and feasibility study of the program. The intervention will last 12 weeks.

Interventions

Internet-mediated pedometer-based intervention with gradually increasing goals and feedback on step counts. Also includes educational content targeted at women who have had gestational diabetes about exercise, diet & nutrition and prevention.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Gestational diabetes diagnosis within past three years * Access to computer with internet, USB port and Windows XP or Vista * Regular email user (weekly or more) * Can walk a block on her own * Sedentary (less than 150 minutes purposeful physical activity per week)

Exclusion criteria

* Pregnancy * Unable to consent legally

Design outcomes

Primary

MeasureTime frame
Weight lossPre-post
Glucose tolerancePre-Post

Secondary

MeasureTime frame
Hemoglobin A1cPre-post
Step countsPre-Post
InsulinPre-post

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026